drugset / Trial / NCT06666634

Validation of ICG-99mTc-nanoscan as Hybrid Tracer for Sentinel Node Biopsy

NCT06666634 ↗

Recruiting 29 enrolled The Netherlands Cancer Institute
NaSingle-groupOpen-labelDiagnostic

Summary

99mTc-nanocolloid, the world wide used hybrid tracer for dynamic sentinel node biopsy, has recently been replaced with 99mTc-nanoscan. The hybrid form (ICG-99mTc-nanoscan) has not yet been validated, to show the similarity between the lymphatic drainage pattern between ICG-99mTc-nanoscan and 99mTc-nanoscan.

Timeline

Start
2023-04-01
Primary completion
2025-08
Completion
2025-08

Drugs

EvaluationDrugModalityDoseRoute
Subject 99mTc-nanoscan Unknown — Other
Subject ICG-99mTc-nanoscan Unknown — Other